Study of skin related adverse effects of chemotherapy drugs and radiotherapy in cancer patients

Not yet recruiting

• Conditions: Disorder of the skin and subcutaneous tissue related to radiation, unspecified,

• Registration Number: CTRI/2023/08/056465
• Lead Sponsor: -

Brief Summary

There is an enormous advancement of chemotherapeutic drugs and in radiotherapy. With the advancement the adverse effects in patient receiving chemotherapeutic drugs and radiotherapy have also increased. Hence identifying and treating adverse effects of chemotherapeutic drugs and radiotherapy is utmost important for patients. This will be an observational prospective study that will be conducted in a tertiary care cancer hospital [Siddharth Gupta Memorial Cancer hospital] and patients coming to OPD of AVBRH in Department of Dermatology over a period of 1.5 years who will be presenting with the mucocutaneous adverse effects. Detailed History and Cutaneous examination will be performed and graded according to Common Terminology Criteria for Adverse Events v5. The various mucocutaneous adverse effects will be compiled and grading will be done. This study will help us to find out the various mucocutaneous adverse effects associated with various new chemotherapeutic drugs and radiation.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-05-24
• Study Start: 2023-08-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Patients receiving chemotherapy and radiotherapy irrespective of their age and sex.
• Patients willing to participate.

Exclusion Criteria

• Patient with mucocutaneous manifestation due to malignancy.
• Known Prior primary dermatoses.
• Drug reaction due to Non-Chemotherapeutic Drugs.
• Mucocutaneous manifestation of Paraneoplastic syndromes.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the various mucocutaneous manifestations in patients with solid organ malignancy or haematological malignancy receiving chemotherapy and radiotherapy.	1 year 2 months

Secondary Outcome Measures

Name	Time	Method
•To find out the frequency of mucocutaneous manifestation in patient receiving chemotherapy.	•To find out the frequency of mucocutaneous manifestation in patient receiving radiotherapy.

Trial Locations

Locations (1)

Siddharth Gupta Memorial Cancer Hospital or Acharya Vinoba Bhave Rural Hospital, Sawangi; 🇮🇳 Wardha, MAHARASHTRA, India

Siddharth Gupta Memorial Cancer Hospital or Acharya Vinoba Bhave Rural Hospital, Sawangi

🇮🇳Wardha, MAHARASHTRA, India

kaveri rusia

Principal investigator

08889889814

kaverirusia12@gmail.com